1. Home
  2. ADM vs RMD Comparison

ADM vs RMD Comparison

Compare ADM & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archer-Daniels-Midland Company

ADM

Archer-Daniels-Midland Company

HOLD

Current Price

$68.42

Market Cap

30.4B

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$228.02

Market Cap

33.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADM
RMD
Founded
1902
1989
Country
United States
United States
Employees
N/A
10600
Industry
Packaged Foods
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.4B
33.2B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
ADM
RMD
Price
$68.42
$228.02
Analyst Decision
Hold
Buy
Analyst Count
5
10
Target Price
$58.80
$293.70
AVG Volume (30 Days)
3.0M
864.8K
Earning Date
05-05-2026
04-22-2026
Dividend Yield
2.94%
1.05%
EPS Growth
N/A
N/A
EPS
2.23
N/A
Revenue
$80,269,000,000.00
N/A
Revenue This Year
$4.49
$10.64
Revenue Next Year
$2.32
$7.38
P/E Ratio
$31.86
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$40.98
$199.92
52 Week High
$73.72
$293.81

Technical Indicators

Market Signals
Indicator
ADM
RMD
Relative Strength Index (RSI) 49.53 29.90
Support Level $57.39 N/A
Resistance Level $70.11 $260.21
Average True Range (ATR) 1.90 5.30
MACD -0.00 -2.55
Stochastic Oscillator 39.72 4.50

Price Performance

Historical Comparison
ADM
RMD

About ADM Archer-Daniels-Midland Company

Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: